
SF Healthcare Week: Baird Senior Analyst Brian Skorney comments on Monday's conference news and highlights his top picks ahead for 2026
BiotechTV - News
00:00
Biogen as a Big‑Cap Pick
Brad asks about Biogen; Brian cites blood biomarkers, subcutaneous dosing, and tau program BIB080 as catalysts.
Play episode from 06:17
Transcript


